Xingyong Wan

1.8k total citations
29 papers, 1.5k citations indexed

About

Xingyong Wan is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Xingyong Wan has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Xingyong Wan's work include Liver Disease Diagnosis and Treatment (15 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Xingyong Wan is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). Xingyong Wan collaborates with scholars based in China, United States and Germany. Xingyong Wan's co-authors include Chaohui Yu, Youming Li, Chengfu Xu, Yiming Lin, Chao Lü, Jiexia Ding, Youming Li, Haijian He, Jianzhong Sang and Meng Li and has published in prestigious journals such as Gastroenterology, PLoS ONE and Gut.

In The Last Decade

Xingyong Wan

27 papers receiving 1.4k citations

Peers

Xingyong Wan
Yaxi Chen China
George Marek United States
Kengo Tomita Japan
Hua Bian China
Derrick M. Van Rooyen Australia
María Eugenia Inzaugarat Germany
Yumie Takeshita Japan
Marica Cariello Italy
Irena Nowak United States
Evelina Maria Gosav Romania
Yaxi Chen China
Xingyong Wan
Citations per year, relative to Xingyong Wan Xingyong Wan (= 1×) peers Yaxi Chen

Countries citing papers authored by Xingyong Wan

Since Specialization
Citations

This map shows the geographic impact of Xingyong Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyong Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyong Wan more than expected).

Fields of papers citing papers by Xingyong Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyong Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyong Wan. The network helps show where Xingyong Wan may publish in the future.

Co-authorship network of co-authors of Xingyong Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyong Wan. A scholar is included among the top collaborators of Xingyong Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyong Wan. Xingyong Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Shen, Weiyan, Xingyong Wan, Jiahui Hou, et al.. (2022). Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis. PubMed. 1(2). 207–220. 6 indexed citations
4.
Lü, Chao, et al.. (2020). Epstein–Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis. Cancer Cell International. 20(1). 401–401. 5 indexed citations
5.
Li, Chunxiao, Jianguo Gao, Xingyong Wan, et al.. (2019). Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways. World Journal of Gastroenterology. 25(34). 5120–5133. 71 indexed citations
6.
Huang, S.H., et al.. (2019). Detection of Gas Leaks from Sea Bed Using A Small Circular Array. OCEANS 2019 - Marseille. 1–5. 3 indexed citations
7.
Li, Meng, Dahua Chen, Jiewei Wang, et al.. (2017). Caveolin1 protects against diet induced hepatic lipid accumulation in mice. PLoS ONE. 12(6). e0178748–e0178748. 33 indexed citations
8.
Li, Meng, Chengfu Xu, Junping Shi, et al.. (2017). Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut. 67(12). 2169–2180. 133 indexed citations
9.
Zhu, Jinzhou, et al.. (2017). Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human. Experimental and Clinical Endocrinology & Diabetes. 125(5). 322–326. 8 indexed citations
10.
Lü, Chao, Jianzhong Sang, Haijian He, et al.. (2016). Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis. Scientific Reports. 6(1). 23522–23522. 76 indexed citations
11.
Zhu, Jinzhou, Xingyong Wan, Yuming Wang, et al.. (2016). Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine. 56(1). 208–211. 35 indexed citations
12.
Zhu, Jinzhou, Kelseanna Hollis‐Hansen, Xingyong Wan, et al.. (2016). Clinical guidelines of non-alcoholic fatty liver disease: A systematic review. World Journal of Gastroenterology. 22(36). 8226–8226. 28 indexed citations
13.
Lin, Yiming, et al.. (2016). Sa1666 IGFBP1 Decreases Free Fatty Acid-Induced Hepatocyte Steatosis through Phosphorylation of FAK. Gastroenterology. 150(4). S1090–S1090.
14.
Zhu, Hua-Tuo, Xingyong Wan, Jing Li, et al.. (2015). Computational Prediction and Validation of BAHD1 as a Novel Molecule for UlcerativeColitis. Scientific Reports. 5(1). 12227–12227. 14 indexed citations
15.
Xu, Chengfu, Xingyong Wan, Lei Xu, et al.. (2015). Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. Journal of Hepatology. 62(6). 1412–1419. 138 indexed citations
16.
Zhu, Jinzhou, Hua-Tuo Zhu, Yi-Ning Dai, et al.. (2015). Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study. Endocrine. 51(1). 91–100. 32 indexed citations
17.
Wan, Xingyong, Chengfu Xu, Yiming Lin, et al.. (2015). Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. Journal of Hepatology. 64(4). 925–932. 271 indexed citations
18.
Ding, Jiexia, Meng Li, Xingyong Wan, et al.. (2015). Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease. Scientific Reports. 5(1). 13729–13729. 215 indexed citations
19.
Wan, Xingyong, Hua-Tuo Zhu, Chao Lü, et al.. (2014). Lipotoxic Effect of p21 on Free Fatty Acid-Induced Steatosis in L02 Cells. PLoS ONE. 9(4). e96124–e96124. 13 indexed citations
20.
Zhu, Jinzhou, et al.. (2014). Is national socioeconomic status related to prevalence of irritable bowel syndrome?. Journal of Gastroenterology and Hepatology. 29(8). 1595–1602. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaxi Chen Breakdown of academic impact, for papers by George Marek Breakdown of academic impact, for papers by Kengo Tomita Breakdown of academic impact, for papers by Hua Bian Breakdown of academic impact, for papers by Derrick M. Van Rooyen Breakdown of academic impact, for papers by María Eugenia Inzaugarat Breakdown of academic impact, for papers by Yumie Takeshita Breakdown of academic impact, for papers by Marica Cariello Breakdown of academic impact, for papers by Irena Nowak Breakdown of academic impact, for papers by Evelina Maria Gosav
Rankless by CCL
2026